DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Targeted Therapy of Breast Cancer
2009 DE LAURENTIIS, Michelino; Zielinski, C.
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.
2003 DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part
2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases.
1996 Carlomagno, Chiara; Perrone, F.; Gallo, C.; DE LAURENTIIS, Michelino; Lauria, R.; Morabito, A.; Pettinato, G.; Bianco, A. R.; DE PLACIDO, Sabino
A Feasibilty Study of a Sequential Dose-Dense Adjuvant Regimen with Epidoxorubicin Followed by Docetaxel Followed by High-Dose Cyclophosphamide for Early Breast Cancer with 4 or More Lymph Node Metastases.
2001 Francesco, Cognetti; Arpino, Grazia; DE LAURENTIIS, Michelino; Paola, Papaldo; Chiara, Sguotti; Modesto, D'Aprile; Francesco, Recchia; DE PLACIDO, Sabino; Angelo Raffaele, Bianco
[Exemestane in the treatment of breast carcinoma: recent findings]
2008 DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano
Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?
1994 C. L., Loprinzi; P. M., Ravdin; DE LAURENTIIS, Michelino; P., Novotny
Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer.
2012 Giordano, A; Gao, H; Anfossi, S; Cohen, E; Mego, M; Lee, Bn; Tin, S; DE LAURENTIIS, Michelino; Parker, Ca; Alvarez, Rh; Valero, V; Ueno, Nt; DE PLACIDO, Sabino; Mani, Sa; Esteva, Fj; Cristofanilli, M; Reuben, Jm
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A.
2000 Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Prognostic factors in human colorectal cancer.
1997 A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
2010 Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino
Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer.
2009 Di Lorenzo, G; Cartenì, G; Autorino, R; Bruni, G; Tudini, M; Rizzo, M; Aieta, M; Gonnella, A; Rescigno, P; Perdonà, S; Giannarini, G; Pignata, S; Longo, N; Palmieri, G; Imbimbo, Ciro; DE LAURENTIIS, Michelino; Mirone, Vincenzo; Ficorella, C; DE PLACIDO, Sabino
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies
2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
TAG-72 expression and clinical outcome in primary breast cancer.
1999 C., Pizzi; A., Sgambato; DE LAURENTIIS, Michelino; Limite, Gennaro; L., Panico; Pettinato, Guido; R., Muraro; L., Tauchmanova; A., Galietta; A. R., Bianco; R., Mariani Costantini; A., Contegiacomo
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial.
2007 Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Valeria, Forestieri; Carmela, Romano; Antonella, Prudente; Francesco, Giugliano; Ciro, Imbimbo; Vincenzo, Mirone; DE PLACIDO, Sabino
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
2006 Ciardiello, F; Troiani, T; Caputo, F; DE LAURENTIIS, Michelino; Tortora, G; Palmieri, Giovannella; De Vita, F; Diadema, Mr; Orditura, M; Colantuoni, G; Gridelli, C; Catalano, G; DE PLACIDO, Sabino; Bianco, A. R.
Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup.
2004 Antonio M., Ippolito; DE LAURENTIIS, Michelino; Giacomo L., La; Antonio, Eleuteri; Roberto, Tagliaferri; DE PLACIDO, Sabino; Riccardo, Vigneri; Antonino, Belfiore
Differential immunohistochemical detection of transforming growth factor , amphiregulin and CRIPTO in human normal and malignant breast tissues.
1996 Panico, L.; D'Antonio, A.; Salvatore, G.; Mazza, E.; Tortora, Giampaolo; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Giordano, T.; Merino, M.; Salomon, D. S.; Gullick, W. J.; Pettinato, Guido; Bianco, A. R.; Ciardiello, F.
Prognosis of chronic myelomonocytic leukemia.
1996 L., Catalano; S., Improta; DE LAURENTIIS, Michelino; S., Molica; I., Majolino; P., Musto; A., Fragasso; DE PLACIDO, Sabino; Rotoli, Bruno
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer.
1995 Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Targeted Therapy of Breast Cancer | 8.01 Chairman di Sessioni di Convegni Internazionali | 2009 | DE LAURENTIIS, Michelino; Zielinski, C. | |
| Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. | 1.1 Articolo in rivista | 2003 | DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino | |
| Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part | 1.5 Abstract in rivista | 2007 | G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino | |
| C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases. | 1.1 Articolo in rivista | 1996 | Carlomagno, Chiara; Perrone, F.; Gallo, C.; DE LAURENTIIS, Michelino; Lauria, R.; Morabito, A.; Pettinato, G.; Bianco, A. R.; DE PLACIDO, Sabino | |
| A Feasibilty Study of a Sequential Dose-Dense Adjuvant Regimen with Epidoxorubicin Followed by Docetaxel Followed by High-Dose Cyclophosphamide for Early Breast Cancer with 4 or More Lymph Node Metastases. | 4.1 Articoli in Atti di convegno | 2001 | Francesco, Cognetti; Arpino, Grazia; DE LAURENTIIS, Michelino; Paola, Papaldo; Chiara, Sguotti; Modesto, D'Aprile; Francesco, Recchia; DE PLACIDO, Sabino; Angelo Raffaele, Bianco | |
| [Exemestane in the treatment of breast carcinoma: recent findings] | 1.1 Articolo in rivista | 2008 | DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano | |
| Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? | 1.1 Articolo in rivista | 1994 | C. L., Loprinzi; P. M., Ravdin; DE LAURENTIIS, Michelino; P., Novotny | |
| Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer. | 1.1 Articolo in rivista | 2012 | Giordano, A; Gao, H; Anfossi, S; Cohen, E; Mego, M; Lee, Bn; Tin, S; DE LAURENTIIS, Michelino; Parker, Ca; Alvarez, Rh; Valero, V; Ueno, Nt; DE PLACIDO, Sabino; Mani, Sa; Esteva, Fj; Cristofanilli, M; Reuben, Jm | |
| Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Prognostic factors in human colorectal cancer. | 1.1 Articolo in rivista | 1997 | A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello | |
| Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. | 1.1 Articolo in rivista | 2010 | Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino | |
| Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer. | 1.1 Articolo in rivista | 2009 | Di Lorenzo, G; Cartenì, G; Autorino, R; Bruni, G; Tudini, M; Rizzo, M; Aieta, M; Gonnella, A; Rescigno, P; Perdonà, S; Giannarini, G; Pignata, S; Longo, N; Palmieri, G; Imbimbo, Ciro; DE LAURENTIIS, Michelino; Mirone, Vincenzo; Ficorella, C; DE PLACIDO, Sabino | |
| HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies | 1.5 Abstract in rivista | 2002 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco | |
| TAG-72 expression and clinical outcome in primary breast cancer. | 1.1 Articolo in rivista | 1999 | C., Pizzi; A., Sgambato; DE LAURENTIIS, Michelino; Limite, Gennaro; L., Panico; Pettinato, Guido; R., Muraro; L., Tauchmanova; A., Galietta; A. R., Bianco; R., Mariani Costantini; A., Contegiacomo | |
| Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial. | 1.1 Articolo in rivista | 2007 | Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Valeria, Forestieri; Carmela, Romano; Antonella, Prudente; Francesco, Giugliano; Ciro, Imbimbo; Vincenzo, Mirone; DE PLACIDO, Sabino | |
| Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer. | 1.1 Articolo in rivista | 2006 | Ciardiello, F; Troiani, T; Caputo, F; DE LAURENTIIS, Michelino; Tortora, G; Palmieri, Giovannella; De Vita, F; Diadema, Mr; Orditura, M; Colantuoni, G; Gridelli, C; Catalano, G; DE PLACIDO, Sabino; Bianco, A. R. | |
| Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup. | 1.1 Articolo in rivista | 2004 | Antonio M., Ippolito; DE LAURENTIIS, Michelino; Giacomo L., La; Antonio, Eleuteri; Roberto, Tagliaferri; DE PLACIDO, Sabino; Riccardo, Vigneri; Antonino, Belfiore | |
| Differential immunohistochemical detection of transforming growth factor , amphiregulin and CRIPTO in human normal and malignant breast tissues. | 1.1 Articolo in rivista | 1996 | Panico, L.; D'Antonio, A.; Salvatore, G.; Mazza, E.; Tortora, Giampaolo; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Giordano, T.; Merino, M.; Salomon, D. S.; Gullick, W. J.; Pettinato, Guido; Bianco, A. R.; Ciardiello, F. | |
| Prognosis of chronic myelomonocytic leukemia. | 1.1 Articolo in rivista | 1996 | L., Catalano; S., Improta; DE LAURENTIIS, Michelino; S., Molica; I., Majolino; P., Musto; A., Fragasso; DE PLACIDO, Sabino; Rotoli, Bruno | |
| Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino |